POCS in Liver Transplantation Patients
Status: | Recruiting |
---|---|
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 3/31/2019 |
Start Date: | January 25, 2018 |
End Date: | August 2020 |
Contact: | Srey Yin |
Email: | srey.yin@bsci.com |
Phone: | 508-683-4162 |
Per-Oral Cholangioscopy in Liver Transplantation Patients
A prospective, multi-center, non-randomized, observational, consecutive case series, which
will compare Endoscopic Retrograde Cholangiopancreatoscopy (ERCP) and cholangioscopy with Spy
Glass Digital System (DS) procedure at 5-10 centers.
will compare Endoscopic Retrograde Cholangiopancreatoscopy (ERCP) and cholangioscopy with Spy
Glass Digital System (DS) procedure at 5-10 centers.
The objective of this study is to demonstrate the clinical utility of cholangioscopy with Spy
Glass Digital System (DS) in cadaveric donor or live donor liver transplantation patients who
are referred for ERCP in the setting of a clinical suspicion of post liver transplant bile
duct stricture(s). A secondary study objective is to generate a hypothesis for a randomized
controlled trial comparing ERCP alone to ERCP with Per- Oral Cholangioscopy (POCS) in
patients referred for ERCP post liver transplantation.
Glass Digital System (DS) in cadaveric donor or live donor liver transplantation patients who
are referred for ERCP in the setting of a clinical suspicion of post liver transplant bile
duct stricture(s). A secondary study objective is to generate a hypothesis for a randomized
controlled trial comparing ERCP alone to ERCP with Per- Oral Cholangioscopy (POCS) in
patients referred for ERCP post liver transplantation.
Inclusion Criteria:
1. Liver transplantation at least 1 month prior to POCS procedure
2. Abnormal Liver Function Tests (LFTs) and/or biliary obstructive symptoms
3. Prior cross sectional imaging (MRI and/or US and/or CT)
4. Suspicion of anastomotic biliary stricture(s)
5. Diameter of bile ducts deemed sufficient to accommodate cholangioscopy system based on
baseline imaging
6. Willing and able to provide a written informed consent to participate in the study
7. Willing and able to comply with study procedures and follow-up schedule
Exclusion Criteria:
1. Contraindication for an ERCP per local standard of practice
2. Deemed contraindicated for POCS per local standard of practice
3. Prior biliary treatment of biliary anastomotic stricture
4. < 18 years old
5. Documented life expectancy of less than 12 months.
We found this trial at
3
sites
630 West 168th Street
New York, New York 10032
New York, New York 10032
Principal Investigator: Amrita Sethi, MD
Phone: 212-305-2862
Click here to add this to my saved trials
200 Lothrop St
Pittsburgh, Pennsylvania 15213
Pittsburgh, Pennsylvania 15213
Principal Investigator: Adam Slivka, MD, PhD
Phone: 412-647-8132
University of Pittsburgh Medical Center UPMC is one of the leading nonprofit health systems in...
Click here to add this to my saved trials
Click here to add this to my saved trials